8 Polen Capital Lilly(Eli) Trades
Polen Capital's position in Lilly(Eli) is currently worth $1.28B. That's 3.88% of their equity portfolio (10th largest holding). The first Lilly(Eli) trade was made in Q3 2023. Since then Polen Capital bought shares two more times and sold shares on five occasions. The stake costed the investor $1.26B, netting the investor a gain of 1.8% so far.
News about Lilly(Eli) & Co and Polen Capital
Baron Capital's Top Health Care Stock Picks And Misses From Q2 2025
We added key positions in Masimo, Exact Sciences, Eli Lilly, Penumbra, and Edwards Lifesciences, each with strong growth drivers and market leadership. Our i...
Eli Lilly and Company (LLY) Q4 2024 Earnings Call Transcript
Eli Lilly and Company (NYSE:LLY ) Q4 2024 Results Conference Call February 6, 2025 10:00 AM ET Company Participants Mike Czapar - Senior Vice President of In...
Eli Lilly and Company (LLY) Q3 2024 Earnings Call Transcript
Eli Lilly and Company (NYSE:LLY ) Q3 2024 Earnings Conference Call October 30, 2024 10:00 AM ET Company Participants Joe Fletcher - Senior Vice President-Inv...
Avalo Acquires Anti-IL-1¦Â mAb and Announces Private Placement Financing of up to $185 Million
Avalo acquires Phase 2-ready anti-IL-1¦Â mAb, AVTX-009, through acquisition of AlmataBio, Inc. Topline results from planned Phase 2 trial in hidradenitis supp...